Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0493-2017

Drug recall · March 15, 2017

Mirtazapine Tablets recall

Why: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Lots / codes

Batch #3083289; Exp. Date 12/2018

Quantity
58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
Company
Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
Distribution
Nationwide
Initiated
January 27, 2017 · Voluntary: Firm initiated
Classified
March 8, 2017
Reported
March 15, 2017
Ended
March 15, 2019
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Mirtazapine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.